CHATSWORTH, Calif.--(BUSINESS WIRE)--Sept. 14, 2006--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a manufacturer and marketer of automated IVD urinalysis systems and medical devices used in hospitals and clinical reference laboratories worldwide, announced today that its Iris Diagnostics Division has entered into a five-year agreement to supply and service automated urine microscopy technology for Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH). In connection with this agreement, the Company also announced that LabCorp has ordered 26 iQ(R)200 SPRINT(TM) Urine Microscopy Analyzers.
